InvestorsHub Logo
Followers 7
Posts 640
Boards Moderated 0
Alias Born 04/21/2008

Re: Den post# 519

Thursday, 09/10/2009 10:36:37 AM

Thursday, September 10, 2009 10:36:37 AM

Post# of 3283
This is a long term riser. Usually bio-pharms don't follow the technicals, except this one. I can only guess that most of the approvals have already been baked into the share price as each date approaches. Which means follow your 50 day moving average and sell on the news if it crawls too far above it. I think it the price should spike a little today, during or after the Rodman&Renshaw annual global investment conference at 11:15am. Look at this as an opportunity to lock in profits and take some off the table, IMO.